Common Stock SEC Reporting - Current
Verified Company Profile 9/06/2016
Contact Info
  • 225 Long Ave.
  • Hillside, NJ 07205

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-K
CIK 0001016504
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 1980
Employees 120 a/o Sep 02, 2016
Company Officers/Contacts
E. Gerald Kay CEO
Dina L. Masi CFO, EVP
Riva Sheppard EVP
Christina Kay EVP
Company Directors
E. Gerald Kay Chairman
Robert Canarick
Carl DeSantis
Christina Kay
Joseph LaPlaca
William Milmore
Riva Sheppard
Company Notes
  • Formerly=Integrated Health Technologies, Inc. until 4-03
  • Formerly=Chem International, Inc. until 1-01
Service Providers
Accounting/Auditing Firm
Friedman LLP
100 Engle Rock Avenue
East Hanover, NJ, 07936
United States

Legal Counsel
Herrick Feinstein
One Gateway Center
Newark, NJ, 07102
United States

Investor Relations Firm
Not Available
INBP Security Details
Share Structure
Market Value1 $3,419,038 a/o Oct 26, 2016
Authorized Shares 50,000,000 a/o Sep 02, 2016
Outstanding Shares 21,105,174 a/o Sep 02, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 9,184,073 a/o Sep 01, 2016
Par Value 0.002
Shareholders of Record 116 a/o Jun 30, 2016
Short Selling Data
Short Interest 92 (100%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security